University Hospitals of Leicester NHS Trust.

Leicester, England LE2 9LX

1 studies enrolling now · 4 studies all time

What they study most

Diffuse Large B-Cell Lymphoma Refractory, Diffuse Large B-cell Lymphoma Recurrent, Epithelioid Hemangioendothelioma (EHE), Macular Edema, Malignant Pleural Mesothelioma (MPM), NF2 Deficiency, NF2 Deficient Mesothelioma, Other NF2 Deficient Solid Tumors and Solid Tumors with YAP1/TAZ Fusion Genes, Patients With Non-Small Cell Lung Cancer, Solid Tumor, Solid Tumors, Adult, Uveitis

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors — Stopped early
• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial — Completed